ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2273

Patient Survey Challenges Conventional Notions Regarding Symptoms and Experiences Of People Living With Rheumatoid Arthritis

Kelly O'Neill Young1, Cynthia S. Crowson2 and Dana M. Symons1, 1Rheumatoid Patient Foundation, Cocoa, FL, 2Department of Health Sciences Research, Mayo Clinic, Rochester, MN

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: Disease Activity, Fatigue, Fever, pain and patient outcomes

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Rheumatoid Arthritis-Clinical Aspects III: Outcome Measures, Socioeconomy, Screening, Biomarkers in Rheumatoid Arthritis

Session Type: Abstract Submissions (ACR)

Background/Purpose: While rheumatoid arthritis (RA) has been studied for decades, many aspects of the disease are not well understood. Like systemic lupus erythematosus, RA manifests with a spectrum of symptoms that vary between patients and may not be accurately reflected in current literature. The goal of this study was to obtain greater understanding of the nature of RA as experienced by patients.

Methods: A 29-item web-based questionnaire was conducted in 2011 by a secure survey system preventing multiple entries. The questionnaire included questions about RA symptoms and treatments. Percentages and averages were used to summarize the data. 320 patients responded to an online poll with a follow-up question on morning stiffness.

Results: The questionnaire was completed by 1,465 self-reported RA patients (93% women and 7% men); 69% were seropositive (31% were seronegative or were unknown). Time since RA diagnosis varied with a mean of 6.6 years, 25% of respondents diagnosed within the past year, and 52% reported having RA symptoms for longer than a year prior to diagnosis. Low-grade fevers were common (80% reported experiencing sometimes) and most (99%) reported sometimes experiencing fatigue. On average, respondents experienced only 2 pain-free days per month with 68% having zero pain-free days in an average month. Pain levels were not affected by length of time since diagnosis and were similar across age groups, except for higher pain levels reported by those ³ 71 years. Physical activity increased pain for 67%, and decreased pain for 18%. The top 3 factors cited as reducing pain were medications, rest and heat. Medications were reported to reduce pain by 80% of respondents, the majority stating that added medications (i.e., steroids, anti-inflammatories and/or pain relievers) were needed beyond disease treatments to address residual RA symptoms. Symptoms were completely controlled by treatments in only 8% of patients with 36% stating they continue to have a lot of symptoms “no matter what.” While 23% of respondents reported they experience the most joint pain and stiffness in the morning, 25% have joint pain and stiffness all day and night; 52% experience some or most pain and stiffness in the evening or after activity. One-third said they always (12%) or usually (21%) have RA symptoms that their rheumatologists “do not believe or understand.” 75% of respondents reported experiencing either joint damage without obvious swelling or having obvious joint swelling with no resulting damage, indicating the two are frequently unassociated.

Conclusion: The data in this survey indicate patient experiences and symptoms do not always reflect what is traditionally presented in the literature concerning RA pain, morning stiffness, the relationship between swelling and damage, and what worsens or improves symptoms. Additional research should seek a broader understanding of the disease experience of RA.


Disclosure:

K. O. Young,
None;

C. S. Crowson,
None;

D. M. Symons,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/patient-survey-challenges-conventional-notions-regarding-symptoms-and-experiences-of-people-living-with-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology